A Milestone in Minimally Invasive Cancer Treatment of Asia
--- Prof. Zhang Fujun, the Leader of Minimally Invasive Cancer Treatment in China, Joined in St. Stamford Modern Cancer Hospital Guangzhou.
Last December 29, 2016, the signing ceremony was successfully held in the headquarters of St. Stamford Modern Cancer Hospital Guangzhou. Professor Zhang Fujun was officially welcomed in MCHG as Chief Expert of Minimally Invasive Cancer Treatment Department. He also acts as the Chairman of Committee of Specialized Minimally Invasive Cancer Treatment in Chinese Anticancer Association and the Director of Department of Radiation Oncology in Sun Yat-Sen University Cancer Hospital.
Officials of China Boai Medical Group and St. Stamford Modern Cancer Hospital Guangzhou attended the signing ceremony lead by Chairman Lin Zhicheng, Medical Director Lin Daoxuan and General Manager of MCHG Lin Shaohua, Hospital President Wang Huaizhong and Multi-disciplinary experts Lin Taijie, Peng Xiaochi and Bai Haishan, among others.
The chairman Lin Zhicheng and Prof. Zhang Fujun
As Professor Zhang Fujun has been hailed as the Chief Expert in St. Stamford Modern Cancer Hospital Guangzhou, it also marks the leap forward of MCHG after it has become the first JCI-accredited China-Singapore Joint Venture hospital in Guangzhou.
St. Stamford Modern Cancer Hospital Guangzhou was founded in 2005 and it has over 10 satellite offices around Southeast Asia. Equipped with cutting-edge cancer techniques, outstanding multidisciplinary team and high-quality humanistic service, the hospital integrates its international medical resources and cooperates in the expertise of minimally invasive cancer treatment Prof. Zhang Fujun. So as to develop an international cooperated department, it also strengthens further the development in international cancer technologies. The process of exploring as such directs St. Stamford Modern Cancer Hospital Guangzhou to consistently fight against the world’s dreadful disease--cancer and to benefit more cancer patients.
Professor Zhang together with the Bo Ai Medical Group Offcials
Professor Zhang Fujun is the Chairman of Specialized Minimally Invasive Cancer Treatment in Chinese Anticancer Association, the Member and Secretary of Committee of Specialized Minimally Invasive Cancer Treatment in Anticancer Association of Guangdong, the Deputy Director of Particle Therapy Team in Chinese Anticancer Association, Editorial Member of Minimally Invasive Surgery and Executive Member of Editorial Board of Imaging and Minimally Invasive Treatment for Cancer.
Prof. Zhang Fujun
His researches focus on cancer therapies including CT-guided radioactive particle implantation, microwave ablation, radiofrequency ablation, HIFU therapy, interventional therapy and near-infrared fluorescence imaging of molecular targets.
Prof. Zhang Fujun was awarded with 3 national patents and an Outstanding Contribution Award granted by committee of specialized minimally invasive cancer treatment in Chinese Anticancer Association. In addition, he wrote Interventional Therapy with CT Guide, Closely Interstitial Radioactive Seeds Treatment for Prostate Cancer, Combination of Minimally Invasive Treatment and Multidisciplinary Treatment for Liver Cancer. He also published over 50 professional academic papers in several leading magazine at home and abroad including Chinese Medical Journal, Cancer Biology and Therapy, Chinese Journal of Radiology, etc.